BRIEF published on 12/09/2025 at 18:35, 3 months 13 days ago Theraclion Submits Sonovein to FDA After Year of Key Achievements FDA Submission Clinical Evidence SONOVEIN Regulatory Achievements Varicose Vein Treatment
BRIEF published on 12/09/2025 at 18:35, 3 months 13 days ago Theraclion submits Sonovein to the FDA after significant progress FDA Theraclion SONOVEIN Varicose Veins HIFU
BRIEF published on 12/09/2025 at 18:35, 3 months 13 days ago Theraclion soumet Sonovein à la FDA après d'importants progrès FDA Theraclion SONOVEIN Varices HIFU
BRIEF published on 12/09/2025 at 18:35, 3 months 13 days ago Theraclion soumet le Sonovein à la FDA après une année de succès clés Soumission À La FDA SONOVEIN Réalisations Réglementaires Traitement Des Varices Preuves Cliniques
PRESS RELEASE published on 12/09/2025 at 18:30, 3 months 13 days ago Informations privilégiées / Autres communiqués Theraclion annonce la soumission de Sonovein à la FDA après une année de progrès réglementaires et cliniques, avec des résultats encourageants et des avancées significatives en Europe et en Chine FDA Theraclion SONOVEIN Varices HIFU
PRESS RELEASE published on 12/09/2025 at 18:30, 3 months 13 days ago Inside Information / Other news releases Theraclion announces FDA submission of Sonovein following a year of regulatory and clinical achievements. Key milestones in Europe and China also reached Clinical Milestones FDA Submission Theraclion SONOVEIN Regulatory Achievements
BRIEF published on 10/29/2025 at 18:35, 4 months 24 days ago Theraclion Announces 2025 Half-Year Financial Results and Strategic Progress Financial Results Revenue Growth Market Expansion U.S. Study Certification Progress
BRIEF published on 10/29/2025 at 18:35, 4 months 24 days ago Theraclion annonce ses résultats financiers et ses progrès stratégiques pour le premier semestre 2025. Résultats Financiers Croissance Des Revenus Expansion Du Marché Étude Américaine Progression De La Certification
PRESS RELEASE published on 10/29/2025 at 18:30, 4 months 24 days ago Inside Information / News release on accounts, results Theraclion reports successful pivotal study, CE certification, GB 9706.1-2020 certification; 89% revenue increase and 23% operating loss reduction in 2025 half-year results Revenue Increase Operating Loss Reduction CE Certification Pivotal Study Theraclion
PRESS RELEASE published on 10/29/2025 at 18:30, 4 months 24 days ago Informations privilégiées / Communiqué sur comptes, résultats Theraclion annonce ses récentes avancées majeures et ses résultats financiers du premier semestre 2025, confirmant une forte efficacité de sa plateforme robotique HIFU pour le traitement des varices Résultats Financiers Theraclion Varices Avancées Majeures HIFU
Published on 03/23/2026 at 14:05, 3 hours 57 minutes ago Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric Disorders
Published on 03/23/2026 at 14:00, 4 hours 2 minutes ago BlackBerry AtHoc Advances Command Center for Faster Response and Tighter Control During Critical Operations
Published on 03/23/2026 at 13:05, 4 hours 57 minutes ago SouthGobi Announces Disclosable and Connected Transaction Deferral of Payment Obligations Under Convertible Debenture and Amended and Restated Cooperation Agreement
Published on 03/23/2026 at 12:32, 5 hours 30 minutes ago Sinopec Announced 2025 Annual Results Annual Payout Ratio Reached 81%
Published on 03/23/2026 at 12:30, 5 hours 32 minutes ago Digi Power X to Announce 2025 Year End Financial Results on March 31st
Published on 03/23/2026 at 17:54, 8 minutes ago EQS-Adhoc: net digital AG publishes 2026 forecast with continued growth in revenue and earnings
Published on 03/23/2026 at 17:45, 17 minutes ago Carvolix joins key Euronext indices, marking a new milestone in its capital markets profile.
Published on 03/23/2026 at 17:45, 17 minutes ago Carvolix rejoint des indices clés d’Euronext, marquant une nouvelle étape dans son positionnement sur les marchés financiers.
Published on 03/23/2026 at 17:44, 18 minutes ago Original-Research: Marinomed Biotech AG (von First Berlin Equity Research GmbH): Buy
Published on 03/23/2026 at 17:00, 1 hour 2 minutes ago Phuket consolide sa position privilégiée pour les familles du monde entier en quête d’un lieu de résidence sûr
Published on 03/23/2026 at 17:45, 17 minutes ago ENGIE will build, own and operate its largest onshore wind farm worldwide in Egypt
Published on 03/23/2026 at 17:45, 17 minutes ago En Égypte, ENGIE va construire et exploiter son plus grand parc éolien terrestre au monde
Published on 03/23/2026 at 17:45, 17 minutes ago Share buyback for allocation to employees or corporate officers
